drugset / Trial / NCT06485752
Phase 3 Lot Consistency Study of Trivalent Hemagglutinin Nanoparticle Influenza Vaccine
RandomizedCrossoverSingle-blindPrevention
Summary
Phase 3 Study Comparing Safety and Immune Response of Three Batches of Novavax Flu Vaccine in older adult participants
Timeline
- Start
- 2024-11
- Primary completion
- 2025-02-04
- Completion
- 2025-02-04
Outcome
Outcome not reported
Stopped: “Decided to not move forward with the study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | tNIV | Unknown | 0.5 ml | Intramuscular |
| Comparator | Matrix-M Adjuvant | Unknown | — | — |